Surgical robotics maker behind the Versius minimal access system
CMR Surgical builds and commercialises the Versius surgical robot from Cambridge, pairing embedded-software and hardware tooling (Altium Designer, SolidWorks, MATLAB, IEC 62304) with a Salesforce, ServiceMax and NetSuite commercial backbone. Hiring is accelerating across engineering, sales and clinical education in markets from the US to Brazil, Egypt and India, which points to a push from regulatory clearance toward installed-base growth and robot utilisation.
Notable leadership hires: Program Director
CMR Surgical is a privately held medical device company founded in 2014 and headquartered in Cambridge, United Kingdom. It develops Versius, a robotic system for minimal access surgery, and sells it to hospitals and healthcare systems directly and through distributors. The company employs 201–500 people and covers hardware design, embedded software, manufacturing, clinical training and field service. Its operations span the United Kingdom, United States, Egypt, Brazil and India.
CMR Surgical uses Altium Designer, SolidWorks and MATLAB for engineering, Python and IEC 62304 for device software, Salesforce, ServiceMax and NetSuite for operations, and AWS, Databricks and Terraform for data and infrastructure.
CMR Surgical is hiring in the United Kingdom, United States, Egypt, Brazil and India, with roles across engineering, sales, clinical education, operations and data.
Current work includes embedded software for its medical devices, a Versius training pathway, Versius system integration, robotic program implementations at hospitals and distributor strategy development.
Other companies in the same industry, closest in size
CMR Surgical's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.